Europe is facing spiralling healthcare costs, driven by an ageing population and the growing burden of chronic diseases. At the same time, demand for cutting-edge treatments is rising — bringing a fundamental question into focus: who should pay for healthcare innovation, and to what extent should health be treated as a business?
MEPs Tilly Metz, from the Greens, and Stine Bosse, from Renew Europe, go head to head to debate how the EU should respond — and what it means for access, affordability and innovation across Europe’s healthcare systems.
Debates over taxation in the pharmaceutical sector are adding another layer, raising concerns about how much profit companies should make from publicly funded research and innovation.
Beyond the immediate pressures, Europe also faces long-term structural challenges. Healthcare systems continue to spend significantly more on treatment than on prevention — prompting questions about sustainability and priorities.
Take a listen to this week’s special episode of The Ring, brought to you from the Euronews Health Summit in Brussels.
","author_name":"Euronews"}